Larazotide
ResearchA tight junction peptide regulator researched for leaky gut, celiac disease, and intestinal permeability. One of the most promising gut barrier research peptides.
Gut HealthImmune Support
Half Life
Short
Time to Results
4-8 weeks
Administration
Oral
🐾 Griffin's Research Scorecard
Research Strength
Human Data
Animal Data
Long-Term Data
Beginner Friendly
Storage Difficulty
Injection Frequency3x daily (oral)
Cost$$$
🐾 Griffin Says...
Larazotide targets the tight junctions between gut cells, which is the actual mechanism of leaky gut. Phase 2b clinical trials in celiac disease showed reduction in gut permeability and symptom improvement. Oral delivery is a huge plus for gut research.
Benefits
- Gut barrier protection
- Tight junction regulation
- Intestinal permeability reduction
- Celiac disease research
- Leaky gut research
Best For
- Gut permeability research
- Celiac disease research
- Digestive health
Body Systems
GastrointestinalImmune
Mechanisms of Action
- Regulates tight junction proteins
- Reduces intestinal permeability
- Antagonizes zonulin pathway
- Protects gut epithelial barrier
Side Effects
| Effect | Frequency | Severity |
|---|---|---|
| Headache | Uncommon | Mild |
| Nausea | Uncommon | Mild |
Contraindications
None well established
Peptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.
Ready to calculate your dose? Use Griffin's Peptide Calculator 🐾
Open Calculator